EMSY inhibits homologous recombination repair and the interferon response, promoting lung cancer immune evasion is a research paper published in Cell (2021). On theSindex it has a DataRank of 0. It has been cited 120 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Health and Medical Research Council
Grant: T32CA193111
National Health and Medical Research Council
Grant: F30CA247020
National Health and Medical Research Council
Grant: T32CA009161
National Health and Medical Research Council
Grant: APP1106545
Stanford Genome Technology Center
Grant: P30CA016087
National Institutes of Health
Grant: K00CA212460
National Institutes of Health
Grant: R37CA222504
National Institutes of Health
Grant: F30CA243205
National Institutes of Health
Grant: R01CA76584
National Institutes of Health
Grant: R01CA227649
National Institutes of Health
Grant: R35CA210263
National Institutes of Health
Grant: R35GM136250
National Institutes of Health
Grant: NHMRC/APP1106545
National Institutes of Health
Grant: NIH/F30CA247020
NIBIB NIH HHS
Grant: P41 EB017183
NCI NIH HHS
Grant: R01 CA076584
Airc Italian Foundation for Cancer Research
Howard Hughes Medical Institute
Marie Curie
Agios Pharmaceuticals
Associazione Italiana per la Ricerca sul Cancro
Bristol-Myers Squibb
LAM Therapeutics
FWCI
6.24
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals